Sequential and Concomitant Therapy With Four Drugs Is Equally Effective for Eradication of H pylori Infection

1994, Helicobacter pylori in peptic ulcer disease, JAMA, 272, 65, 10.1001/jama.1994.03520010077036 Teh, 1994, Seroprevalence and associated risk factors of Helicobacter pylori infection in Taiwan, Anticancer Res, 14, 1389 Malfertheiner, 2007, Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report, Gut, 56, 772, 10.1136/gut.2006.101634 Bytzer, 2005, Treatment of Helicobacter pylori, Helicobacter, 10, 40, 10.1111/j.1523-5378.2005.00333.x Vakil, 2007, Eradication therapy for Helicobacter pylori, Gastroenterology, 133, 985, 10.1053/j.gastro.2007.07.008 Yamaoka, 2008, Should triple therapy for Helicobacter pylori infection be abandoned as no longer effective?, US Gastroenterology, 4, 65 Huang, 2000, Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy, J Formos Med Assoc, 99, 704 Zanten, 1999, The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy, Aliment Pharmacol Ther, 13, 289, 10.1046/j.1365-2036.1999.00471.x Sheu, 2002, Impact of supplement with Lactobacillus- and Bifidobacterium-containing yogurt on triple therapy for Helicobacter pylori eradication, Aliment Pharmacol Ther, 16, 1669, 10.1046/j.1365-2036.2002.01335.x Bazzoli, 2002, Helicobacter pylori: the challenge in therapy, Helicobacter, 7, 43, 10.1046/j.1523-5378.7.s1.7.x Georgopoulos, 2002, Effectiveness of two quadruple, tetracycline- or clarithromycin-containing, second-line, Helicobacter pylori eradication therapies, Aliment Pharmacol Ther, 16, 569, 10.1046/j.1365-2036.2002.01220.x Peitz, 2002, High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study, Aliment Pharmacol Ther, 16, 315, 10.1046/j.1365-2036.2002.01173.x Vakil, 2004, Seven-day therapy for Helicobacter pylori in the United States, Aliment Pharmacol Ther, 20, 99, 10.1111/j.1365-2036.2004.02029.x Fuccio, 2007, Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication, Ann Intern Med, 147, 553, 10.7326/0003-4819-147-8-200710160-00008 Zagari, 2007, Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study, Gut, 56, 475, 10.1136/gut.2006.102269 Graham, 2007, A report card to grade Helicobacter pylori therapy, Helicobacter, 12, 275, 10.1111/j.1523-5378.2007.00518.x Fischbach, 2007, Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori, Aliment Pharmacol Ther, 26, 343, 10.1111/j.1365-2036.2007.03386.x Zullo, 2000, A new highly effective short-term therapy schedule for Helicobacter pylori eradication, Aliment Pharmacol Ther, 14, 715, 10.1046/j.1365-2036.2000.00766.x Jafri, 2008, Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment, Ann Intern Med, 148, 923, 10.7326/0003-4819-148-12-200806170-00226 Vaira, 2007, Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial, Ann Intern Med, 146, 556, 10.7326/0003-4819-146-8-200704170-00006 Sanchez-Delgado, 2008, Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice, Am J Gastroenterol, 103, 2220, 10.1111/j.1572-0241.2008.01924.x Treiber, 1998, Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication, Helicobacter, 3, 54, 10.1046/j.1523-5378.1998.08019.x Okada, 1998, A new quadruple therapy for the eradication of Helicobacter pylori, J Gastroenterol, 33, 640, 10.1007/s005350050150 Essa, 2009, Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing “concomitant therapy” versus triple therapy for Helicobacter pylori eradication, Helicobacter, 14, 109, 10.1111/j.1523-5378.2009.00671.x Hu, 2007, Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan, J Gastroenterol Hepatol, 22, 720 Poon, 2009, Prevalence of antimicrobial resistance in Helicobacter pylori isolates in Taiwan in relation to consumption of antimicrobial agents, Int J Antimicrob Agents, 34, 162, 10.1016/j.ijantimicag.2009.02.007 Chang, 2009, Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan, J Gastroenterol Hepatol, 24, 1230, 10.1111/j.1440-1746.2009.05829.x Kuo, 2009, Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial, J Antimicrob Chemother, 63, 1017, 10.1093/jac/dkp034 Wu, 2006, Randomized comparison of two rescue therapies for Helicobacter pylori infection, Eur J Clin Invest, 36, 803, 10.1111/j.1365-2362.2006.01725.x Wu, 2003, Evaluation of a newly developed office-based stool test for detecting Helicobacter pylori: an extensive pilot study, Hepatogastroenterology, 50, 1761 Hsu, 2002, Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island, Am J Gastroenterol, 97, 2231, 10.1111/j.1572-0241.2002.05977.x Alarcon, 1999, Antibiotic resistance problems with Helicobacter pylori, Int J Antimicrob Agents, 12, 19, 10.1016/S0924-8579(99)00051-5 Graham, 2009, Efficient identification and evaluation of effective Helicobacter pylori therapies, Clin Gastroenterol Hepatol, 7, 145, 10.1016/j.cgh.2008.10.024 Okada, 1999, A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome, Aliment Pharmacol Ther, 13, 769, 10.1046/j.1365-2036.1999.00551.x Treiber, 2002, Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study), Arch Intern Med, 162, 153, 10.1001/archinte.162.2.153 Scott, 1998, The life and death of Helicobacter pylori, Gut, 43, S56, 10.1136/gut.43.2008.S56 Graham, 2008, New concepts of resistance in the treatment of Helicobacter pylori infections, Nat Clin Pract Gastroenterol Hepatol, 5, 331, 10.1038/ncpgasthep1138 Moayyedi, 2007, Sequential regimens for Helicobacter pylori eradication, Lancet, 370, 1010, 10.1016/S0140-6736(07)61455-X Graham, 2008, Therapy for Helicobacter pylori infection can be improved: sequential therapy and beyond, Drugs, 68, 725, 10.2165/00003495-200868060-00001 Suzuki, 2006, Smoking increases the treatment failure for Helicobacter pylori eradication, Am J Med, 119, 217, 10.1016/j.amjmed.2005.10.003 Broutet, 2003, Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients, Aliment Pharmacol Ther, 17, 99, 10.1046/j.1365-2036.2003.01396.x